The U S Food and Drug Administration has requested an allocation of $8.4 billion,  a nearly 34 percent increase over the previous year’s $6.3 billion, as part of the President’s fiscal year 2023 budget for investments in critical public health modernization, core food safety and medical product safety programs and other vital public health infrastructure. The request includes $3.7 billion in budget authority – including an increase of $356 million, and $3 billion in user fees – an increase of $153 million. It also includes $1.6 billion in mandatory funding to support the FDA’s ability to prepare for future pandemics.